Al Childers

Directeur/Membre du Conseil chez Expression Analysis, Inc.

Profil

Dr. Childers is the former president of administration for Cardinal Health Pharmaceutical Development.
He co-founded Magellan Laboratories and engineered the sale of it to Cardinal Health, Inc., a Fortune 50 company.
With a reported acquisition price in excess of $200 million, this was one of the largest acquisitions in North Carolina for the past few years.
In 1998, Dr. Childers was named Entrepreneur of the Year for North and South Carolina by Ernst and Young, The Kauffman Foundation, USA Today, and NASDAQ and was a Finalist for the 1998 National Entrepreneur of The Year.
Before joining Glaxo, Dr. Childers was a principal investigator at the Upjohn Company, and was responsible for analytical development for Controlled released tablets, parenterals, and inhalation aerosols.
Dr. Childers received two awards from the Council for Entrepreneurial Development, the 2002 Entrepreneurial Excellence Award and the 2002 Deal of the Year Award.
Prior to starting Magellan Laboratories, he developed and managed the Inhalation Analysis Department for Glaxo-SmithKline.
Dr. Childers received his PhD in Analytical Chemistry from Indiana University under the direction of Dr. Gary H.
Hieftje and his BS in chemistry from Furman University.
He has authored over 40 articles and presentations in the area of pharmaceutical and analytical science.
Dr. Childers is on the board and serves as an advisor to several early-stage life science companies.

Postes actifs de Al Childers

Sociétés	Poste	Début
Expression Analysis, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Al Childers

Sociétés	Poste	Fin
Glaxo, Inc.	Corporate Officer/Principal	-
The Upjohn Co.	Corporate Officer/Principal	-
Magellan Laboratories, Inc.	Corporate Officer/Principal	-
CARDINAL HEALTH, INC.	President	-